The Peculiarities of Six-Minute Walk Test in Patients with Chronic Obstructive Pulmonary Disease, Some with Normal Weight and Some Overweight

ORIGINAL ARTICLE
Evgeniy S. Ovsyannikov, Andrey V. Budnevsky, Lilia A. Titova, Anastasia S. Ivanova, Anastasia S. Kachur

 
International Journal of Biomedicine. 2022;12(4):530-534.
DOI: 10.21103/Article12(4)_OA1
Originally published December 5, 2022

Abstract: 

Background: The combination of chronic obstructive pulmonary disease (COPD) and overweight/obesity is a common clinical situation in modern healthcare. The objective of this study was to conduct a comparative analysis of exercise tolerance in normal body weight (NBW) and overweight patients with COPD in the 6MWT using the original device for cardiorespiratory analysis and a method for assessing the cardiorespiratory condition.
Methods and Results: The study included 194 patients with COPD. The patients were divided into two groups. Group 1 consisted of 96 COPD patients with NBW: 77(80.21%) men and 19(19.79%) women aged 41 to 73 years (mean age of 63.33 ± 8.44 years). Group 2 consisted of 98 overweight COPD patients: 74(75.51%) men and 24(24.49%) women aged 55 to 71 (mean age of 64.84 ± 5.46 years).
To assess tolerance to physical activity and to objectify the functional status of patients, the 6MWT was used and carried out according to generally accepted principles. The distance covered in 6 minutes (6MWD) was measured in meters and compared with the proper 6MWD(i).
The developed device for cardiorespiratory analysis was used to obtain the most accurate 6MWT result. All patients in the study groups underwent an analysis of the composition of the body by the bioelectrical impedance method using a fat mass analyzer BC-555 (Tanita Corporation, Tokyo, Japan). The percentages of fat, water, muscle mass (MM), and bone mass were evaluated.
The average value of the 6MWD/6MWD(i) ratio in COPD patients with NBW was significantly lower than in COPD patients with overweight (P=0.0121). Before the test, the study groups did not differ in the level of SpO2. However, according to the results of comparative analysis, this parameter was significantly lower in patients with NBW immediately after the 6MWT (P=0.0000), which, along with a lower value of the distance traveled as a percentage of the proper value in Group 1 patients, may indicate a lower tolerance to physical activity in COPD patients with NBW than in patients with overweight. In COPD patients with NBW, the percentage of fat and MM were significantly lower than in COPD patients with overweight (P=0.0000 in both cases). There was a direct correlation between 6MWD and body mass index (r=0.56, P=0.003) and between 6MWD and MM percentage (r=0.59, P=0.016).
Conclusion: Higher exercise tolerance is found in overweight COPD patients than in COPD patients with NBW. This phenomenon can be explained to some extent by the compositional components of the body, in particular, by a significantly lower percentage of lean MM in patients with NBW.

Keywords: 
chronic obstructive pulmonary disease • overweight • six-minute walk test
References: 
  1. Giri Ravindran S, Saha D, Iqbal I, Jhaveri S, Avanthika C, Naagendran MS, Bethineedi LD, Santhosh T. The Obesity Paradox in Chronic Heart Disease and Chronic Obstructive Pulmonary Disease. Cureus. 2022 Jun 5;14(6):e25674. doi: 10.7759/cureus.25674.
  2. Samuleeva YuV, Zadionchenko VS, Li VV, Adasheva TV, Samorukova EI, Pikhlak AE, Logachev VA, Sokolova LB. Obesity and metabolic disorders in COPD patients: opportunities for phenotyping. PULMONOLOGIYA. 2014;(5):32-38. doi: 10.18093/0869-0189-2014-0-5-32-38. [ Article in Russian].
  3.  WHO: Chronic obstructive pulmonary disease (COPD) [ May; 2022 ]; Avail­able from: https://www.who.int/news-room/fact-sheets/detail/chronic-obstructive-pul...(copd)
  4.  Lavie CJ, De Schutter A, Parto P, Jahangir E, Kokkinos P, Ortega FB, Arena R, Milani RV. Obesity and Prevalence of Cardiovascular Diseases and Prognosis-The Obesity Paradox Updated. Prog Cardiovasc Dis. 2016 Mar-Apr;58(5):537-47. doi: 10.1016/j.pcad.2016.01.008. 
  5. Global Initiative for Chronic Obstructive Lung Disease (GOLD). Global Strategy for the Diagnosis, Management, and Prevention of Chronic Obstructive Pulmonary Disease: 2022 Report. Avail­able from: https://goldcopd.org/2022-gold-reports/
  6. Ots ON, Maliev BM, Chushkin MI, Mandrykin YuV, Yartsev SS. [Use of walk tests in pulmonology]. Ter Arkh. 2012;84(3):62-7. [Article in Russian].
  7. Tokmachev RE, Maksimov AV, Budnevsky AV, Batishcheva GA, Ovsyannikov ES, Kravchenko AYa, Kurgalin SD. Device for cardiorespiratory analysis and method for assessing cardiorespiratory condition. Patent RF N 2 637 917. 2017.[ In Russian].
  8.  Chittal P, Babu AS, Lavie CJ. Obesity paradox: does fat alter outcomes in chronic obstructive pulmonary disease? COPD. 2015 Feb;12(1):14-8. doi: 10.3109/15412555.2014.915934. 
  9.  Yohannes AM. The Paradox of Obesity in Patients with Chronic Obstructive Pulmonary Disease. Ann Am Thorac Soc. 2022 Oct;19(10):1638-1639. doi: 10.1513/AnnalsATS.202206-525ED.
  10.  Budnevsky AV, Malysh EY. [Clinico-Pathogenetic Relationship of Cardiovascular Diseases and Chronic Obstructive Pulmonary Disease]. Kardiologiia. 2017 Apr;57(4):89-93. [Article in Russian].
  11. Provotorov VM, Budnevskiĭ AV, Semenkova GG, Shishkina ES. [PROINFLAMMATORY CYTOKINES IN COMBINATION OF CORONARY HEART DISEASE AND CHRONIC OBSTRUCTIVE PULMONARY DISEASE]. Klin Med (Mosk). 2015;93(2):5-9. [Article in Russian].
  12.  Budnevskiy AV, Tsvetikova LN, Ovsyannikov ES, Goncharenko OV. A role of melatonin for occurrence of chronic obstructive pulmonary disease.  Pulmonologiya, 2016, 26(3), 372–378. doi:10.18093/086990189920166266333722378 [Article in Russian].
  13.  Kozhevnikova SA, Budnevskiy AV, Ovsyannikov ES, Belov VN. Particularity of the clinical course and quality of life of patients with chronic obstructive pulmonary disease on the background of the metabolic syndrome. Medical News of North Caucasus. 2017;12(1):20–23. doi:10.14300/mnnc.2017.12006. [Article in Russian].
  14. Matos Casano HA, Anjum F. Six Minute Walk Test. 2022 Jun 19. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2022 Jan–. PMID: 35015445.
  15.  Chikina SYu. The role of the 6-minute walk test in the management of patients with bronchopulmonary diseases. Practical pulmonology. 2015; N4: 34-38. [Article in Russian].
  16. van Gestel AJ, Clarenbach CF, Stöwhas AC, Teschler S, Russi EW, Teschler H, Kohler M. Prevalence and prediction of exercise-induced oxygen desaturation in patients with chronic obstructive pulmonary disease. Respiration. 2012;84(5):353-9. doi: 10.1159/000332833. 
  17. Minai OA, Gudavalli R, Mummadi S, Liu X, McCarthy K, Dweik RA. Heart rate recovery predicts clinical worsening in patients with pulmonary arterial hypertension. Am J Respir Crit Care Med. 2012 Feb 15;185(4):400-8. doi: 10.1164/rccm.201105-0848OC. 
  18. Singh SJ, Puhan MA, Andrianopoulos V, Hernandes NA, Mitchell KE, Hill CJ, Lee AL, Camillo CA, Troosters T, Spruit MA, Carlin BW, Wanger J, Pepin V, Saey D, Pitta F, Kaminsky DA, McCormack MC, MacIntyre N, Culver BH, Sciurba FC, Revill SM, Delafosse V, Holland AE. An official systematic review of the European Respiratory Society/American Thoracic Society: measurement properties of field walking tests in chronic respiratory disease. Eur Respir J. 2014 Dec;44(6):1447-78. doi: 10.1183/09031936.00150414. 
  19. Budnevsky AV, Isaeva YV, Malysh EY, Kozhevnikova SA. [Pulmonary rehabilitation as an effective method for optimizing therapeutic and preventive measures in patients with chronic obstructive pulmonary disease concurrent with metabolic syndrome]. Ter Arkh. 2016;88(8):25-29. doi: 10.17116/terarkh201688825-29. [Article in Russian].

Download Article
Received October 18, 2022.
Accepted November 28, 2022.
©2022 International Medical Research and Development Corporation.